Sign in
4

Changes in Ownership

CYTOKINETICS INC Filed Acc 0001127602-25-005237

EVP Research & Development sold 2,000 shares at $45.98 ($91,960)

  • EVP Research & Development acquired 2,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Malik Fady Ibraham EVP Research & Development 2025-02-18 Option exercise 10b5-1 +2,000 $10.60 $21,200 118,071 D
Malik Fady Ibraham EVP Research & Development 2025-02-18 Sale 10b5-1 −2,000 $45.98 $91,960 116,071 D
Derivatives
Malik Fady Ibraham EVP Research & Development 2025-02-18 Option exercise · Non-Qualified Stock Option (Right to Buy) 10b5-1 −2,000 33,105 D
Open-market sales · 2,000 sh · avg $45.98 · $91,960
Loading xslF345X05/form4.xml…